معرفی
Badr Al Bawardy is an Adjunct Assistant Professor of Medicine (Digestive Diseases) at Yale School of Medicine. He specializes in gastroenterology with a focus on inflammatory bowel disease (IBD), including Crohn’s disease and ulcerative colitis. His clinical expertise includes diagnostic endoscopic procedures such as EGD, colonoscopy, and video capsule endoscopy. Dr. Al Bawardy completed his MD at George Washington University and advanced training at the Mayo Clinic, including a fellowship in IBD. His research emphasizes IBD epidemiology, treatment outcomes, and regional healthcare practices, particularly in the Middle East and Saudi Arabia.
Education:
- MD, George Washington University (2011)
- Internal Medicine Residency, Mayo Clinic (2014)
- Gastroenterology Fellowship, Mayo Clinic (2017)
- IBD Fellowship, Mayo Clinic (2018)
Research Interests: Dr. Al Bawardy investigates IBD pathophysiology, treatment optimization (e.g., mirikizumab, ustekinumab), and cross-cultural healthcare practices. His work includes studies on colorectal neoplasia in IBD, antibiotic therapies for PSC-IBD overlap, and regional disparities in disease management.
Awards:
- 2021 Healthcare Honored Hero (Crohn's and Colitis Foundation)
- 2020 Young Investigator Travel Grant (Crohn's and Colitis Foundation)
- 2018 Howard M. Spiro Fellowship (Yale School of Medicine)
Advocacy & Grants: Leads initiatives to improve IBD care in underserved regions, including Saudi Arabian consensus guidelines for pediatric and adult IBD management. Collaborates with global networks like the MIRAGE study to analyze IBD demographics in the Middle East and North Africa.
Labs/Teams: Active in Yale’s Inflammatory Bowel Disease Program and Spondyloarthritis Program, contributing to multidisciplinary care models and translational research.
